Actively Recruiting
Study of Brain Radiation Using Hippocampal-Sparing Whole Brain Radiotherapy and Stereotactic Radiotherapy for Extensive-Stage Small Cell Lung Cancer with Brain Metastases
Led by Fudan University · Updated on 2024-02-07
56
Participants Needed
1
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of hippocampal-sparing whole brain radiotherapy WBRT combined with stereotactic radiotherapy SRS as a first-line treatment for patients with extensive-stage small cell lung cancer SCLC who have brain metastases. The study addresses the need to improve control of brain lesions in the era of chemotherapy and immunotherapy, as current WBRT treatments have limited long-term control and may cause cognitive side effects. This trial aims to assess whether combining these radiation techniques can offer better outcomes for these patients. Participants will receive hippocampal-avoidance WBRT followed by SRS targeting visible brain metastases while undergoing standard first-line chemotherapy combined with immunotherapy using PD-1 or PD-L1 monoclonal antibodies. This treatment approach uses doses and methods shown to be safe in other lung cancer brain metastases and follows guidelines recommending hippocampal protection to preserve cognitive function. The study includes a dose fractionation schedule to evaluate the treatments safety and efficacy in this patient group. During the study, participants will undergo brain imaging and other baseline scans before starting treatment. Researchers will monitor dose-limiting toxicities within 30 days after the final radiotherapy session and assess intracranial progression-free survival at one year. Additional evaluations will include overall survival, time to brain progression, and cognitive function tests focusing on learning, memory, processing speed, and executive function over a year. Participants will be followed closely to collect safety and efficacy data throughout the study period.
CONDITIONS
Brief Title
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Research Team
Z
zhengfei zhu
X
Xiao Chu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here